A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population

被引:235
|
作者
Staehling-Hampton, K
Proll, S
Paeper, BW
Zhao, L
Charmley, P
Brown, A
Gardner, JC
Galas, D
Schatzman, RC
Beighton, P
Papapoulos, S
Hamersma, H
Brunkow, ME
机构
[1] Celltech R&D Inc, Bothell, WA 98021 USA
[2] Univ Cape Town, Sch Med, Dept Human Genet, ZA-7700 Rondebosch, South Africa
[3] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Leiden, Netherlands
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 2002年 / 110卷 / 02期
关键词
endosteal hyperostoses; sclerosteosis; chromosomal deletion; van Buchem disease; SOST/AF326739; MEOX1/U10492;
D O I
10.1002/ajmg.10401
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Van Buchem disease is an autosomal recessive sclerosing bone dysplasia characterized by skeletal hyperostosis, overgrowth of the mandible, and a liability to entrapment of the seventh and eighth cranial nerves. The genetic determinant maps to chromosome 17q12-q21. We refined the critical interval to the < 1-Mb region between D17S2250 and D17S2253 in 15 affected individuals, all of whom shared a common disease haplotype. Furthermore, we report here the identification of a 52-kb deletion located within the interval and encompassing D17S1789 that is 100% concordant with the disorder. Although the deletion itself does not appear to disrupt the coding region of any known or novel gene(s), the closest flanking genes are MEOX1 on the proximal side, and SOST on the distal side of the deletion. MEOX1 is known to be important for the development of the axial skeleton, whereas the SOST gene is the determinant of sclerosteosis, a disorder that shares many features with van Buchem disease, thus raising the possibility that van Buchem disease results from dysregulation of the expression of one or both of these genes. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:144 / 152
页数:9
相关论文
共 7 条
  • [1] Genetic mapping of the gene for van Buchem disease to chromosome 17q12-q21
    Balemans, W
    Van Hul, E
    Dikkers, F
    Stokroos, R
    Van Camp, G
    Willems, P
    Van Hul, W
    EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 : 39 - 39
  • [2] Van Buchem disease (hyperostosis corticalis generalisata) maps to chromosome 17q12-q21
    Van Hul, W
    Balemans, W
    Van Hul, E
    Dikkers, FG
    Obee, H
    Stokroos, RJ
    Hildering, P
    Vanhoenacker, F
    Van Camp, G
    Willems, PJ
    AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (02) : 391 - 399
  • [3] Localization of the gene for sclerosteosis to the van Buchem Disease-gene region on chromosome 17q12-q21
    Balemans, W
    Van Den Ende, J
    Paes-Alves, AF
    Dikkers, FG
    Willems, PJ
    Vanhoenacker, F
    de Almeida-Melo, N
    Alves, CF
    Stratakis, CA
    Hill, SC
    Van Hul, W
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (06) : 1661 - 1669
  • [4] The autosomal dominant form of Van Buchem disease (Worth disease) is not linked to chromosome 17q12-q21.
    Balemans, W
    Scopelliti, D
    Sugar, A
    Dikkers, F
    Maria, J
    Moesker, W
    Van Hul, W
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S483 - S483
  • [5] LINKAGE TO MARKERS FOR THE CHROMOSOME REGION 17Q12-Q21 IN 13 DUTCH BREAST-CANCER KINDREDS
    DEVILEE, P
    CORNELIS, RS
    BOOTSMA, A
    BARDOEL, A
    VANVLIET, M
    VANLEEUWEN, I
    CLETON, FJ
    DEKLEIN, A
    LINDHOUT, D
    VASEN, HFA
    CORNELISSE, CJ
    KHAN, PM
    AMERICAN JOURNAL OF HUMAN GENETICS, 1993, 52 (04) : 730 - 735
  • [6] THE GENE FOR HEREDITARY BREAST-OVARIAN CANCER, BRCA1, MAPS DISTAL TO EDH17B2 IN CHROMOSOME REGION 17Q12-Q21
    TONIN, P
    SEROVA, O
    SIMARD, J
    LENOIR, G
    FEUNTEUN, J
    MORGAN, K
    LYNCH, H
    NAROD, S
    HUMAN MOLECULAR GENETICS, 1994, 3 (09) : 1679 - 1682
  • [7] Variants associated with autoimmune Type 1 diabetes in Japanese children: implications for age-specific effects of cis-regulatory haplotypes at 17q12-q21
    Ayabe, T.
    Fukami, M.
    Ogata, T.
    Kawamura, T.
    Urakami, T.
    Kikuchi, N.
    Yokota, I.
    Ihara, K.
    Takemoto, K.
    Mukai, T.
    Nishii, A.
    Kikuchi, T.
    Mori, T.
    Shimura, N.
    Sasaki, G.
    Kizu, R.
    Takubo, N.
    Soneda, S.
    Fujisawa, T.
    Takaya, R.
    Kizaki, Z.
    Kanzaki, S.
    Hanaki, K.
    Matsuura, N.
    Kasahara, Y.
    Kosaka, K.
    Takahashi, T.
    Minamitani, K.
    Matsuo, S.
    Mochizuki, H.
    Kobayashi, K.
    Koike, A.
    Horikawa, R.
    Teno, S.
    Tsubouchi, K.
    Mochizuki, T.
    Igarashi, Y.
    Amemiya, S.
    Sugihara, S.
    DIABETIC MEDICINE, 2016, 33 (12) : 1717 - 1722